WO1997028105A1 - Processes for the reduction of carbonyl compounds - Google Patents
Processes for the reduction of carbonyl compounds Download PDFInfo
- Publication number
- WO1997028105A1 WO1997028105A1 PCT/JP1997/000189 JP9700189W WO9728105A1 WO 1997028105 A1 WO1997028105 A1 WO 1997028105A1 JP 9700189 W JP9700189 W JP 9700189W WO 9728105 A1 WO9728105 A1 WO 9728105A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- substituted
- carbon atoms
- general formula
- unsubstituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B53/00—Asymmetric syntheses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B41/00—Formation or introduction of functional groups containing oxygen
- C07B41/02—Formation or introduction of functional groups containing oxygen of hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
Definitions
- the present invention relates to a method for sending a carbonyl compound.
- the source of carbonyl compounds is a very important technology in various fields such as the production of pharmaceutical intermediates.
- practical methods for reducing carbonyl compounds include, for example, Meerweinn Ponddorf-Varley reduction (MPV reduction), reduction using diisobutylaluminum hydride (DIB AH), and the like. Can be mentioned.
- MPV reduction is a method of passing a carbonyl compound using an aluminum trialkoxide such as Al (OiPr) 3 as a reducing agent or a reduction catalyst.
- the alcohol used such as aluminum trialkoxydisopropanol, is inexpensive, and is often used as a source of various ketone aldehydes as an economical reduction technique.
- the mouth of Eris refers to an isomer in which an adjacent amino group and a hydroxyl group have a relative configuration represented by the following formula.
- dialkyl aluminum monoalkoxides such as diisobutylaluminum isopropoxide are used to reduce or reduce carbonyl compounds.
- dialkyl aluminum monoalkoxides such as diisobutylaluminum isopropoxide
- a reducing agent prepared from a dialkylaluminum hydride such as diisobutylaluminum hydride and an alcohol such as isopropanol is effective for reducing a carbonyl compound or for stereoselective reduction.
- a reducing agent prepared from a dialkylaluminum hydride such as diisobutylaluminum hydride and an alcohol such as isopropanol is effective for reducing a carbonyl compound or for stereoselective reduction. unknown. Summary of the Invention
- an object of the present invention is to provide a method for reducing a carboxy compound to a hydroxy compound easily and under milder conditions.
- the present invention provides a method for reducing a certain carbonyl compound in which the reaction hardly progresses to a hydroxy compound, and particularly provides a method for stereoselectively reducing an ⁇ -aminoketone derivative. is there.
- the gist of the present invention is to reduce a carbonyl compound by the following general formula (1):
- R ′ and R 2 are independently a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted aralkyl group having 1 to 30 carbon atoms, 6 to 30 substituted or unsubstituted aryl groups, cyano groups, hydrogen atoms, the following general formula (2): CH n X e _ n (2)
- Y represents an alkoxyl group, an aralkyloxyl group, a substituted or unsubstituted amino group, or an alkylthio group.
- R 1 and R ⁇ a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, carbon number?
- R 3 and R 4 are independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 20 carbon atoms, or Represents a substituted or unsubstituted aryl group having 6 to 20 carbon atoms
- R 5 is a substituted or unsubstituted primary alkyl group having 1 to 20 carbon atoms, and substituted or unsubstituted having 1 to 20 carbon atoms.
- Secondary alkyl group, carbon number? ⁇ 3 Q substitution Is the unsubstituted or substituted aralkyl group or carbon number? Represents up to 30 substituted or unsubstituted secondary aralkyl groups.
- FIG. 1 shows the NMR spectrum of t-butyl ester of [1 (S) -benzyl 2 (S) -hydroquinone—3-chlorochloroporuyl] obtained in Example 5.
- FIG. 1 shows the NMR spectrum of t-butyl ester of [1 (S) -benzyl 2 (S) -hydroquinone—3-chlorochloroporuyl] obtained in Example 5.
- FIG. 2 shows the IR spectrum of [1- (S) -benzyl-2 (S) -hydroquinone-3-chlorobutyryl] potassium t-butyl ester obtained in Example 5.
- FIG. 2 shows the IR spectrum of [1- (S) -benzyl-2 (S) -hydroquinone-3-chlorobutyryl] potassium t-butyl ester obtained in Example 5.
- FIG. 3 is a diagram showing an NMR spectrum of [1 (S) -benzyl-2 (S) -hydroxy-3- (chloropropyl)] methyl carbamic acid ester obtained in Example 8.
- FIG. 4 is a diagram showing an IR spectrum of [1 (S) —benzyl-2- (S) —hydroxymethyl 3-cyclopropyl] capillamic acid methyl ester obtained in Example 8.
- FIG. 5 shows that [1 (R) -phenylthiomethyl-2 (S) -hydroxyl-3-chloropropyl] obtained in Example 9 benzylsulfonate
- FIG. 3 is a view showing a NMR spectrum of Teru;
- FIG. 6 is a diagram showing the IR spectrum of benzyl ester carbamic acid [1 (R) -furthiothiomethyl-2 (S) -hydroxy-3-chlorobutyl] obtained in Example 9.
- FIG. 7 shows the NMR spectrum of 2 (R, S) -hydroquinine-3 (S)-(t-butynecarbonylamino) -14-methyl obtained in Example i4.
- FIG. 8 shows the IR spectrum of 2 (R.S) -hydroxy-3 (S)-(t-butoxycarbonylamino) -14-methyl 4-phenylbutyrate obtained in Example 14.
- FIG. 9 shows the NMR spectrum of the [1 (S) -benzyl-2 (R, S) -hydroxy-3,3-dichlorobutene pill] -potassium benzyl ester obtained in Example 15.
- FIG. 9 shows the NMR spectrum of the [1 (S) -benzyl-2 (R, S) -hydroxy-3,3-dichlorobutene pill] -potassium benzyl ester obtained in Example 15.
- FIG. 10 shows the IR spectrum of the benzoyl ester of [1 (S) -benzyl-2 (R, S) -hydroxy-3,3-dichloromethane] obtained in Example 15.
- R ′ and R 2 are each independently a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, or a substituted or unsubstituted alkyl group having 7 to 30 carbon atoms.
- a substituted aralkyl group, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a cyano group, a hydrogen atom, a group represented by the above general formula (2), or a group represented by the above general formula (3) Represents a group to be formed.
- R 'and R 2 are substituted young properly unsubstituted alkyl group having a carbon number of 1-3 0, a substituted or unsubstituted carbon number 7-3 0 Araru A kill group or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
- substituents examples include a halogen atom, an alkoxycarbonyl group, an alkoxyl group, a protected amino group, a cyano group, a nitro group, a sulfinyl group, a sulfonyl group, and an alkylthio group. Two or more of these substituents may be substituted.
- the substituted or unsubstituted alkyl group having 1 to 30 carbon atoms is not particularly limited, and examples thereof include a methyl group, an ethyl group, a butyl group, an isopropyl group, and a cyclohexyl group. Preferably, it has 1 to 20 carbon atoms.
- the above-mentioned substituted or unsubstituted aralkyl group having 7 to 30 carbon atoms is not particularly limited, and examples thereof include a benzyl group, a phenylpropyl group, a phenylethyl group, a p-methoxybenzyl group, and 1— (N—t— Butoxycarbonylamino) 1-2-phenylethyl group, 1- (N-benzyloxycarbonylamino) -12-phenylethyl group and the like.
- it has 7 to 20 carbon atoms.
- the substituted or unsubstituted aryl group having 6 to 30 carbon atoms is not particularly limited, and examples thereof include a phenyl group, a p-chlorophenyl group, a p-ditrophenyl group, and a naphthyl group. Preferably, it has 6 to 20 carbon atoms.
- N represents an integer of 0 to 2.
- the halogen atom is not particularly limited, and examples thereof include a chlorine atom, a bromine atom, an iodine atom, and a fluorine atom. Preferably, it is a chlorine atom.
- the group represented by the general formula (2) is not particularly limited. Loromethyl, dichloromethyl, trichloromethyl, bromomethyl, dibromomethyl, tribromomethyl, full-methylmethyl, difluoromethyl, trifluoromethyl, iodomethyl, jadomethyl And a triiodomethyl group.
- they are a chloromethyl group, a dichloromethyl group, and a trichloromethyl group.
- Y represents an alkoxyl group, an aralkyloxyl group, a substituted or unsubstituted amino group, or an alkylthio group.
- the alkoxyl group is not particularly limited, and includes, for example, a methoxy group, an ethoxy group, a t-butoxy group and the like. Preferably, it has 1 to 10 carbon atoms.
- the above aralkyloxyl group is not particularly limited, and examples thereof include a benzyloxyl group. Preferably, it has 6 to 20 carbon atoms.
- the substituted or non-substituted amino group is not particularly limited, and examples thereof include an amino group and a dimethylamino group.
- the alkylthio group is not particularly limited, and examples thereof include a methylthio group and a phenylthio group.
- the group represented by the general formula (3) is not particularly limited, and examples thereof include a methkincarbonyl group, an ethoxyquincarbonyl group, a benzylokinecarbonyl group, and a t-butoxycarbonyl group. . Preferably, they are a methoxycarbonyl group and an ethoxyquincarbonyl group.
- Examples of the carbonyl compound represented by the above general formula [1] include aldehydes such as benzaldehyde, isobutyl aldehyde, etc .; acetophenone, propyl benzone, cyclohexanone, acetohexanone and acetophenone.
- the substituted or unsubstituted alkyl group having 1 to 10 carbon atoms is not particularly limited, and examples thereof include a methyl group, an ethyl group, an n-butyl group, an isobutyl group and an isopropyl group. And cyclohexyl, methoxymethyl and the like. Preferably, it has 1 to 6 carbon atoms, and more preferably, isobutyl.
- the substituted or unsubstituted aralkyl group of -20 to 20 is not particularly limited, and examples thereof include a benzyl group, a 3-phenyl-11-propyl group, an ⁇ -phenylethyl group, and a ⁇ -methoxybenzyl group. Can be mentioned. Preferably, carbon number? ⁇ 15.
- the substituted or unsubstituted aryl group having 6 to 20 carbon atoms is not particularly limited, and examples thereof include a phenyl group, a p-hydroxyphenyl group, and a p-hydroxy group. Examples thereof include a chlorophenyl group, a p-ditrophenyl group, and a naphthyl group. Preferably, it has 6 to 15 carbon atoms.
- they Preferably, they have 1 to 10 carbon atoms, and more preferably, they are an isopropyl group, a cyclohexyl group, and a 2,4-dimethyl-3-pentyl group.
- R 5 the number of carbon atoms?
- Examples of the substituted or unsubstituted primary aralkyl group having up to 30 or substituted or unsubstituted secondary aralkyl groups having 7 to 30 carbon atoms include a benzhydryl group, a benzyl group and a phenylpropyl group. Group, ⁇ -phenylethyl group, ⁇ -methoxybenzyl group and the like. Preferably, it has 7 to 15 carbon atoms, and more preferably, it is a benzhydryl group.
- organoaluminum compound represented by the general formula (4) examples include, for example, diisobutylaluminum isopropoxide, diisobutylaluminum dimethyldifunhylmethoxide, diisobutylaluminum dimethyloxide, diisobutylaluminumcyclohexoxide, Diisobutylaluminum-2,4-dimethyl-3-pentyloxide, getylaluminum ethoxide and the like.
- the organoaluminum compounds represented by the above general formula (4) include, for example, 1) the reaction of a dialkylaluminum hydride with an alcohol, 2) the reaction of a trialkylaluminum with an alcohol (German Patent No. 25075) Three
- the method for transferring the carbonyl compound of the present invention is represented by the following general formula (6).
- the present invention can be applied to the reduction of ⁇ -aminoketone derivatives and the transfer of ⁇ - aminohaloketone derivatives represented by the following general formula (7).
- an ⁇ -amino alcohol derivative represented by the following general formula (8) is produced from a monoaminoketone derivative represented by the following general formula (6).
- An ⁇ -aminohalohydrin derivative represented by the following general formula (9) is produced from an aminohaloketone derivative represented by the following general formula (7).
- These ⁇ -amino alcohol derivatives and ⁇ -amino halohydrin derivatives are useful compounds as intermediates of pharmaceuticals.
- the method for producing the amino alcohol derivative is represented by the following general formula (6):
- R 6 is a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aralkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aralkyl group having 6 to 20 carbon atoms.
- R ′ represents an aryl group or a water-cord atom of S.
- R ′ represents a group represented by the above general formula (2) or a group represented by the above general formula (3)
- P 1 , P 2 independently represents a hydrogen atom or an amino-protecting group, or P ′ and P 2 are taken together to represent a phthaloyl group, provided that P ′ and P 2 are simultaneously a hydrogen atom
- the amino haloketone derivative represented by the general formula (7) is a side chain of a general ⁇ -amino acid, or ⁇ — obtained by processing a general ⁇ -amino acid. It is the side chain of the amino acid derivative and has carbon number! Up to 20 substituted or unsubstituted alkyl groups, carbon number? And represents a substituted or unsubstituted aralkyl group having from 20 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, or a hydrogen atom.
- the above substituted or unsubstituted alkyl group having 1 to 20 carbon atoms is not particularly limited. Examples thereof include a methyl group, an ethyl group, an isopropyl group, an isopropyl group, a t-butyl group, a hydroxymethyl group, and a 1-hydroxyquinethyl group. Group, mercaptomethyl group, methylthiomethyl group and the like. Preferably, it has 1 to 10 carbon atoms.
- the above-mentioned substituted or unsubstituted aralkyl group having 7 to 20 carbon atoms is not particularly limited, and examples thereof include a benzyl group, a p-hydroxybenzyl group, a p-methoxybenzyl group, a phenylthiomethyl group, ⁇ _phenethyl group and the like can be mentioned. Preferably, it has 7 to 15 carbon atoms.
- the substituted or unsubstituted aryl group having 6 to 20 ring atoms is not particularly limited, and examples thereof include a phenyl group, a ⁇ -hydroxyphenyl group, and a ⁇ -methoxyphenyl group. Preferably, it has 6 to 15 carbon atoms.
- [rho ', [rho 2 are independently hydrogen It represents a protecting group for an atom or an amino group, or ⁇ 1 and ⁇ 2 together represent a phthaloyl group. However, this does not apply to cases where ⁇ 1 and ⁇ 2 are both hydrogen atoms.
- the protecting group for the above amino group is not particularly limited as long as it has a protective effect on the general reaction.
- the protective group may be a protective group. ⁇ Organic 'Synthesis 2nd Edition, 2nd Ed., By Theodora W. Green, John' Willie 'Ann. Ethkin carbonyl group, methoxy carbonyl group, and t-butyne as described on pages 309 to 384 of JOHN WILEY & S ONS (published in 1991).
- Examples thereof include a carbonyl group, a benzyloxycarbonyl group, an acetyl group, a trifluoracetyl group, a benzyl group, a dibenzyl group, a tosyl group, a benzoyl group, and a fluoryl group.
- the protecting group for the above amino group is preferably selected in consideration of the stereoselectivity of the reduction reaction.
- Examples of the protecting group for the amino group include alkoxycarbonyl groups such as a methoxycarbonyl group, a t-butynecarbonyl group, and an ethoxyquincarbonyl group.
- the reduction reaction can be advanced with high erythroselectivity by using an aralkyl group such as a benzyloquincarbonyl group.
- R 1 represents a group represented by the general formula (2) or a group represented by the general formula (3).
- X represents a halogen atom.
- the halogen atom is not particularly limited, and examples thereof include a chlorine atom, a bromine atom, an iodine atom, and a fluorine atom. Preferably, it is a chlorine atom.
- the ⁇ -aminoketone derivative represented by the above general formula (6) is not particularly limited, and may be, for example, an optically active (S) — (1 benzene-3—chloro—2—oxopropyl) pyruvamin Acid t-butyl ester, (R)-(1-benzyl-13-chloro-2-oxopropyl) potamic acid t-butyl Methyl ester of (S)-(1-benzyl-3-chloro-2-oxopropyl) capillate, (R) — (1-benzyl-3-chloro-2-oxopropyl) potassium methyl ester, (S ) — (1-benzyl-3-chloro-2-benzoyl pill) ethyl ester, (R)-(1 benzyl 3-chloro 2-oxopropyl) ethyl ester, (S ) — (1-Fenylthiomethyl-13-chlor
- the ⁇ -aminohaloketone derivative represented by the above general formula (7) is not particularly restricted but includes, for example, optically active (S) — (1 benzene-3—chloro-2-oxopropyl) capillate _Butyl ester, (R) -1- (1-benzyl-13-chloro-2-oxopropyl) carbamic acid t-Butyl ester, (S) — (1-Benzyl 3-chloro-1-2-year-old pill) Rubamic acid methyl ester, (R) — (1 — Benzyl-3- 3 — chloro-2 — oxopropyl) methyl ester of rubamic acid, (S) — (1 — Benzyl-3-chloro-2-oxopropyl) carbamic acid Ethyl ester, (R)-(1-Benzyl-3—chloro-1-2-oxopropyl) ethyl ester, (S)-(1-
- a carbonyl compound represented by the above general formula (1) is added to a reaction system, or a source agent is added to a carbonyl compound represented by the above general formula (1). Then, the carbonyl compound represented by the general formula (1) is reduced by stirring.
- the reduction temperature is 110 to 60. C is preferred. More preferably, it is 110 to 30 ° C.
- the amount of the organoaluminum compound represented by the general formula (4) is preferably 1 to 5 molar equivalents with respect to the carbonyl compound represented by the general formula (1), more preferably , 1.5 to 3 molar equivalents.
- the solvent used in the present invention is not particularly limited.
- As the solvent other than the alcohol toluene, tetrahydrofuran, hexane and the like are preferable.
- the post-treatment method is not particularly limited.For example, after completion of the reaction, the reaction solution is hydrolyzed with an aqueous acid solution, extracted and concentrated, and then subjected to ordinary post-treatment and isolation procedures such as column isolation, crystallization, and distillation. The resulting alcohol compound represented by the above general formula (5) can be obtained.
- the compound represented by the above general formula (4) can also be prepared by the following reaction. Therefore, it can be used for reduction of the carbonyl compounds represented by the general formulas (1), (6) and (7).
- R 3 and R 4 are independently a substituted or unsubstituted alkyl group having a prime number of 1 to 10 or a substituted or unsubstituted aralkyl group having a carbon number of 7 to 20. And a substituted or unsubstituted aryl group having 6 to 20 carbon atoms.
- R 6 is a substituted or unsubstituted primary alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted secondary alkyl group having 1 to 20 carbon atoms, and an anonymous 7 to 30 carbon atom.
- organoaluminum compound represented by the general formula (10) examples include getyl aluminum hydride, diisobutyl aluminum hydride, and the like. Preferably, it is disobutyl aluminum hydride.
- Examples of the alcohol compound represented by the general formula (11) include hydrogen It is not particularly limited as long as it has a high donor capacity, and examples thereof include isopropanol, benzhydrol, 2,4-dimethyl-13-pentanol, cyclohexanol, and 2-methoxycyclohexanol. Wear.
- R 8 and R s represent a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 20 carbon atoms, or a carbon number of 6 to 10.
- 20 represents an unsubstituted or unsubstituted aryl group, or R e and R 9 are taken together to represent a cycloalkyl group.
- Examples of the substituted or unsubstituted alkyl group having 1 to 10 carbon atoms include a methyl group, an ethyl group, and an isopropyl group. Preferably, it is a methyl group.
- Examples of the substituted or unsubstituted aralkyl group having 7 to 20 carbon atoms include a benzyl group, a phenylpropyl group, a monophenylethyl group, and a p-methoxybenzyl group.
- Examples of the substituted or unsubstituted aryl group having 6 to 20 carbon atoms include a phenyl group, a p-hydroxyphenyl group, a p-chlorophenyl group, a p-nitrophenyl group, and a naphthyl group. Can be.
- cycloalkyl group examples include a cyclohexyl group and a cyclopentyl group.
- the method for reducing a carbonyl compound of the present invention can be performed, for example, as follows.
- a reducing agent is prepared by reacting an organoaluminum compound represented by the above general formula (10) with an alcohol compound represented by the above general formula (11).
- the addition amount of the organoaluminum compound represented by the above general formula (10) is preferably 1 to 5 molar equivalents to the carbonyl compound represented by the above general formula (1), and more preferably. Is 1.5 to 3 molar equivalents.
- the amount of the alcohol compound represented by the general formula (11) is preferably an amount that does not become 3 molar equivalents with respect to the organic aluminum compound represented by the general formula (10). Preferably, it is 1-2 molar equivalents.
- the method of reacting the organoaluminum compound represented by the general formula (10) with the alcohol compound represented by the general formula (11) to obtain a reducing agent includes, for example, the method represented by the general formula (1) 0) to a toluene solution, a tetrahydrofuran solution, a hexane solution, or the like of the organoaluminum compound represented by the formula (11), followed by stirring. be able to.
- the addition conditions are not particularly limited, but are preferably 10 to 60 ° C, more preferably 0 to 40 ° C.
- the stirring conditions are not particularly limited, but 0 to 30 ° C. It is preferred that this is done for 1 to 10 hours.
- the reaction can be carried out by adding an organoaluminum compound represented by the general formula (10) to the alcohol compound represented by the general formula (11).
- a carbonyl compound represented by the above general formula (1) is added to the reaction system, or a reducing agent is added to the carbonyl compound represented by the above general formula (1).
- a source of the carbonyl compound represented by the general formula (1) is performed.
- the starting temperature is preferably from ⁇ 10 to 60 ° C. More preferably, it is 110 to 30 ° C.
- the carbonyl compound is reduced using an alkyl aluminum alkoxide different from that derived from the carbonyl compound as a reactant.
- the speed of the intermediate formation is increased and the reaction at a low temperature is performed.
- the ⁇ -amino alcohol derivative represented by the general formula (8) and the amino group represented by the general formula (9) can be obtained.
- Erythro isomers of amino halohydrin derivatives can be produced with extremely high stereoselectivity.
- the optically active (S) — (1 benzyl-3—chloro-2-oxopropyl) porbamate, which is a phenylalanine derivative the diastereomer excess of 94% or more ( The corresponding optically active amino halohydrin is obtained in de).
- the corresponding optically active aminohalohydrin is surprisingly obtained at a diastereomer excess of 98%.
- (S)-(t-butoxycarbonylamino) 1-2-oxo The corresponding optically active r-hydroxy ester can be obtained with high erythro-selectivity even when the source of methyl 4-phenylbutyrate is used.
- the ⁇ -aminohaloketone derivative represented by the general formula (7) which is a raw material, is usually prepared from ⁇ -amino acid derivatives such as ⁇ -amino acid esters, for example, magnesium ⁇ -chloroacetic acid.
- Figure 1 shows the NMR spectrum of the obtained [1 (S) -benzyl-2 (S) -hydroquinine-13-chloropropyl] carbamic acid t-butyl ester
- Fig. 2 shows the IR spectrum.
- FIG. 3 shows the NMR spectrum of the propylamine methyl ester
- FIG. 4 shows the IR spectrum.
- FIG. 7 shows the N MR spectrum of the obtained 2- (R, S) -hydroxy-3- (S)-(t-butyne carbonylamino) methyl 4-phenylbutyrate
- Fig. 8 shows the IR spectrum. It was shown to.
- Example 15 Preparation of [1 (S) -benzyl-1,3,3-dichlorobutyryl-2- (S) -hydroquine] ethyl ethyl ester (V)
- Fig. 9 shows the NMR spectrum of the obtained [1 (S) -benzyl-1 (R, S) -hydroquinine-1,3,3-dichloropropane] benzyl ester of carbamic acid, and its IR spectrum Is shown in FIG. Reference Example 1 Production of t-butyl t-butyl ester [1- (S) -benzyl-2 (S), 3-epoxypropyl]
- a carbonyl compound can be easily and selectively passed to a hydroxy compound at lower temperature and lower temperature, for example, the amino acid derived from fujyuranalanin etc.
- a nohaloketone derivative an aminohalohydrin derivative that is a useful intermediate of a pharmaceutical can be produced under mild conditions and with extremely high stereoselectivity.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69722111T DE69722111T2 (de) | 1996-01-29 | 1997-01-29 | Verfahren zur reduktion von carbonylverbindungen |
EP97901761A EP0827943B1 (en) | 1996-01-29 | 1997-01-29 | Processes for the reduction of carbonyl compounds |
US08/930,011 US6150567A (en) | 1996-01-29 | 1997-01-29 | Process for the reduction of carbonyl compounds |
JP52748397A JP4545830B2 (ja) | 1996-01-29 | 1997-01-29 | カルボニル化合物の還元方法 |
AT97901761T ATE240918T1 (de) | 1996-01-29 | 1997-01-29 | Verfahren zur reduktion von carbonylverbindungen |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3563296 | 1996-01-29 | ||
JP8/35632 | 1996-01-29 | ||
JP8/37256 | 1996-01-30 | ||
JP3725696 | 1996-01-30 | ||
JP11031796 | 1996-04-04 | ||
JP8/110317 | 1996-04-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997028105A1 true WO1997028105A1 (en) | 1997-08-07 |
Family
ID=27288817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1997/000189 WO1997028105A1 (en) | 1996-01-29 | 1997-01-29 | Processes for the reduction of carbonyl compounds |
Country Status (9)
Country | Link |
---|---|
US (1) | US6150567A (ja) |
EP (1) | EP0827943B1 (ja) |
JP (1) | JP4545830B2 (ja) |
KR (1) | KR19980703369A (ja) |
AT (1) | ATE240918T1 (ja) |
CA (1) | CA2216537A1 (ja) |
DE (1) | DE69722111T2 (ja) |
HU (1) | HUP9800085A3 (ja) |
WO (1) | WO1997028105A1 (ja) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998007687A1 (en) * | 1996-08-16 | 1998-02-26 | Kaneka Corporation | PROCESS FOR PREPARING β-AMINO-α-HYDROXY ACID DERIVATIVES |
WO1998055452A1 (en) * | 1997-06-03 | 1998-12-10 | Kaneka Corporation | PROCESS FOR REDUCING $G(a)-AMINO KETONES |
US6573399B1 (en) | 1999-03-10 | 2003-06-03 | Kaneka Corporation | Synthesis of α-amino-α′, α′-dihaloketones and process for the preparation of β-amino acid derivatives by the use of the same |
US7834037B2 (en) | 2005-11-04 | 2010-11-16 | Amira Pharmaceuticals, Inc. | 5-lipoxygenase-activating protein (FLAP) inhibitors |
US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
US8399666B2 (en) | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
US8772495B2 (en) | 2008-05-23 | 2014-07-08 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein inhibitor |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1160310C (zh) * | 1996-09-13 | 2004-08-04 | 日本化药株式会社 | 生产光学活性的赤-3-氨基-2-羟基丁酸酯及其酸的方法 |
CA2273643A1 (en) * | 1998-06-09 | 1999-12-09 | F. Hoffmann-La Roche Ag | Stereoselective reduction of carbonyl compounds |
US7122696B2 (en) | 2000-11-30 | 2006-10-17 | Ajinomoto Co., Inc. | Processes for preparation of N-protected-β-amino alcohols and N-protected-β-amino epoxides |
US7842727B2 (en) | 2001-03-27 | 2010-11-30 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
EP1511477A4 (en) | 2002-05-22 | 2008-04-09 | Errant Gene Therapeutics Llc | HISTONE DEACETYLASE INHIBITORS BASED ON ALPHA-KETO-EPOXYDE COMPOUNDS |
AU2003247390A1 (en) * | 2002-05-22 | 2003-12-12 | Errant Gene Therapeutics, Llc. | Histone deacetylase inhibitors based on alphachalcogenmethylcarbonyl compounds |
EP1846350A2 (en) * | 2005-01-27 | 2007-10-24 | University of Nottingham | Improved method for the preparation of enantiomerically enriched secondary alcohols by the addition of organoaluminium reagents to carbonyl compounds |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54154739A (en) * | 1978-05-26 | 1979-12-06 | Ono Pharmaceut Co Ltd | Reducing agents |
JPS62286938A (ja) * | 1986-06-05 | 1987-12-12 | インタ−ナショナル ビジネス マシ−ンズ コ−ポレ−ション | アルミニウムアルコキシドまたはアルミニウムアリ−ルオキシドの製造方法 |
JPS632935A (ja) * | 1986-06-20 | 1988-01-07 | Sumitomo Chem Co Ltd | 光学活性アルコ−ル類の製造方法 |
JPS63297333A (ja) * | 1987-05-29 | 1988-12-05 | Asahi Chem Ind Co Ltd | 1,3−ジクロル−2−プロパノ−ルの製造法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5434265A (en) * | 1992-12-22 | 1995-07-18 | Eli Lilly And Company | Inhibitors of HIV protease |
US5591885A (en) * | 1994-09-23 | 1997-01-07 | Hoffman-La Roche Inc. | Process for the preparation of halogenated α-aminoketone compounds |
US5523463A (en) * | 1994-09-23 | 1996-06-04 | Hoffmann-La Roche Inc. | Method of producing halogenated and alpha-aminoalchohols |
-
1997
- 1997-01-29 HU HU9800085A patent/HUP9800085A3/hu unknown
- 1997-01-29 WO PCT/JP1997/000189 patent/WO1997028105A1/ja not_active Application Discontinuation
- 1997-01-29 JP JP52748397A patent/JP4545830B2/ja not_active Expired - Fee Related
- 1997-01-29 KR KR1019970706774A patent/KR19980703369A/ko not_active Application Discontinuation
- 1997-01-29 AT AT97901761T patent/ATE240918T1/de not_active IP Right Cessation
- 1997-01-29 US US08/930,011 patent/US6150567A/en not_active Expired - Fee Related
- 1997-01-29 EP EP97901761A patent/EP0827943B1/en not_active Expired - Lifetime
- 1997-01-29 CA CA002216537A patent/CA2216537A1/en not_active Abandoned
- 1997-01-29 DE DE69722111T patent/DE69722111T2/de not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54154739A (en) * | 1978-05-26 | 1979-12-06 | Ono Pharmaceut Co Ltd | Reducing agents |
JPS62286938A (ja) * | 1986-06-05 | 1987-12-12 | インタ−ナショナル ビジネス マシ−ンズ コ−ポレ−ション | アルミニウムアルコキシドまたはアルミニウムアリ−ルオキシドの製造方法 |
JPS632935A (ja) * | 1986-06-20 | 1988-01-07 | Sumitomo Chem Co Ltd | 光学活性アルコ−ル類の製造方法 |
JPS63297333A (ja) * | 1987-05-29 | 1988-12-05 | Asahi Chem Ind Co Ltd | 1,3−ジクロル−2−プロパノ−ルの製造法 |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998007687A1 (en) * | 1996-08-16 | 1998-02-26 | Kaneka Corporation | PROCESS FOR PREPARING β-AMINO-α-HYDROXY ACID DERIVATIVES |
WO1998055452A1 (en) * | 1997-06-03 | 1998-12-10 | Kaneka Corporation | PROCESS FOR REDUCING $G(a)-AMINO KETONES |
US6573399B1 (en) | 1999-03-10 | 2003-06-03 | Kaneka Corporation | Synthesis of α-amino-α′, α′-dihaloketones and process for the preparation of β-amino acid derivatives by the use of the same |
US7834037B2 (en) | 2005-11-04 | 2010-11-16 | Amira Pharmaceuticals, Inc. | 5-lipoxygenase-activating protein (FLAP) inhibitors |
US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
US8399666B2 (en) | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
US8710081B2 (en) | 2005-11-04 | 2014-04-29 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
US8841295B2 (en) | 2005-11-04 | 2014-09-23 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
US8772495B2 (en) | 2008-05-23 | 2014-07-08 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein inhibitor |
Also Published As
Publication number | Publication date |
---|---|
EP0827943A4 (en) | 2000-07-26 |
HUP9800085A2 (hu) | 1998-05-28 |
KR19980703369A (ko) | 1998-10-15 |
JP4545830B2 (ja) | 2010-09-15 |
ATE240918T1 (de) | 2003-06-15 |
DE69722111D1 (de) | 2003-06-26 |
US6150567A (en) | 2000-11-21 |
EP0827943A1 (en) | 1998-03-11 |
DE69722111T2 (de) | 2004-02-19 |
EP0827943B1 (en) | 2003-05-21 |
CA2216537A1 (en) | 1997-08-07 |
HUP9800085A3 (en) | 1998-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1997028105A1 (en) | Processes for the reduction of carbonyl compounds | |
JP4170753B2 (ja) | オキサゾリジノン化合物の製造方法 | |
JP3665343B2 (ja) | α−ハロケトン、α−ハロヒドリン及びエポキシドの製造法 | |
US9944599B2 (en) | Processes for the preparation of beta-aminosulfone compounds | |
US6087530A (en) | Process for preparing β-amino-α-hydroxy acid derivatives | |
US6906224B2 (en) | Process for producing α-aminoketones | |
WO2022014414A1 (ja) | 光学活性な化合物の製造方法 | |
WO1998055452A1 (en) | PROCESS FOR REDUCING $G(a)-AMINO KETONES | |
JP4143787B2 (ja) | α−アミノハロメチルケトン誘導体の製造方法 | |
JP2004217591A (ja) | シス選択的フルオロシクロプロパン誘導体の製造方法 | |
US7057066B2 (en) | Process for producing 3-amino-2-hydroxypropionic acid derivatives | |
US20200199072A1 (en) | Resolution of racemic beta-aminosulfone compounds | |
EP2448916B1 (en) | Production of trans-4-aminocyclopent-2-ene-1-carboxylic acid derivatives | |
KR100597259B1 (ko) | 광학활성 (r)-2-페녹시프로피온산 유도체의 제조방법 | |
US20030130326A1 (en) | 1,3,4-oxadiazole derivatives and process for producing the same | |
KR100445781B1 (ko) | (s)-1-아세틸-2-피롤리딘카복스아미드의 제조방법 | |
WO2000053575A1 (fr) | SYNTHESE DE α-AMINO-α',α'-DIHALOCETONES ET PROCEDE DE PREPARATION DE DERIVES D'ACIDES AMINES β PAR UTILISATION DE CES DERNIERS | |
JP2000239225A (ja) | 光学活性ヒドロキシエステル化合物の製造方法 | |
JP2002275138A (ja) | 2−アミノインダン誘導体の製造方法およびその中間体 | |
JP2004250340A (ja) | 4−ヒドラジノテトラヒドロピラン化合物又はその酸塩の製法 | |
JPH1045721A (ja) | 1−置換−4,5−ジフェニル−2−イミダゾリジノンの製造法及びこれに用いる中間体 | |
JP2001342173A (ja) | 芳香族カルボン酸誘導体の製造方法 | |
JP2006249097A (ja) | β−アミノ−α−ヒドロキシ酸誘導体の製造方法 | |
JP2003342267A (ja) | エポキシブタン酸エステル類の製造方法 | |
JP2002080470A (ja) | エポキシド結晶の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 97190044.2 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA CN HU JP KR SG US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
ENP | Entry into the national phase |
Ref document number: 2216537 Country of ref document: CA Ref document number: 2216537 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019970706774 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997901761 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 08930011 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1997901761 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019970706774 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1997901761 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1019970706774 Country of ref document: KR |